SIRACUSA, Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 7.280
EU - Europa 3.592
AS - Asia 3.507
SA - Sud America 619
AF - Africa 438
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.441
Nazione #
US - Stati Uniti d'America 6.963
SG - Singapore 1.824
RU - Federazione Russa 1.066
CN - Cina 932
IE - Irlanda 584
UA - Ucraina 558
BR - Brasile 530
IT - Italia 323
DE - Germania 311
VN - Vietnam 303
CA - Canada 271
CI - Costa d'Avorio 242
FR - Francia 213
FI - Finlandia 182
GB - Regno Unito 102
KR - Corea 94
IN - India 88
SE - Svezia 79
NG - Nigeria 66
SN - Senegal 45
PL - Polonia 44
BD - Bangladesh 37
UZ - Uzbekistan 37
AR - Argentina 35
HK - Hong Kong 31
NL - Olanda 30
ZA - Sudafrica 29
JP - Giappone 28
MX - Messico 26
IQ - Iraq 25
KE - Kenya 22
ES - Italia 21
IR - Iran 16
TR - Turchia 16
VE - Venezuela 15
CH - Svizzera 13
EC - Ecuador 12
GR - Grecia 12
TN - Tunisia 12
AT - Austria 11
MA - Marocco 11
PK - Pakistan 11
ID - Indonesia 10
CO - Colombia 9
JM - Giamaica 9
LB - Libano 8
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
JO - Giordania 6
IL - Israele 5
LT - Lituania 5
PE - Perù 5
PY - Paraguay 5
AL - Albania 4
DZ - Algeria 4
EG - Egitto 4
EU - Europa 4
MY - Malesia 4
RO - Romania 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CL - Cile 3
DK - Danimarca 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
UY - Uruguay 3
BO - Bolivia 2
ET - Etiopia 2
MD - Moldavia 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BE - Belgio 1
BH - Bahrain 1
BT - Bhutan 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.441
Città #
Dallas 1.270
Singapore 1.039
Chandler 706
Jacksonville 591
Dublin 583
Santa Clara 566
San Jose 549
Ashburn 421
Moscow 417
Munich 271
Boardman 252
Abidjan 242
Chicago 220
Toronto 190
Nanjing 184
Andover 166
Cambridge 166
Lawrence 164
Helsinki 155
Lauterbourg 149
Civitanova Marche 132
San Mateo 121
Beijing 111
Los Angeles 102
Seoul 94
Des Moines 93
Dong Ket 88
Ho Chi Minh City 76
Hefei 71
Wilmington 69
Nanchang 67
Catania 66
Shenyang 63
New York 55
São Paulo 55
Hanoi 49
Dakar 45
Tianjin 42
Buffalo 39
Jiaxing 39
Saint Petersburg 39
Ottawa 38
Changsha 36
Hebei 35
Lagos 34
Brooklyn 32
Warsaw 30
Orem 29
Tokyo 26
Abuja 25
Council Bluffs 25
Hong Kong 25
Atlanta 22
Montreal 22
Belo Horizonte 21
Houston 21
Tashkent 21
The Dalles 21
Columbus 20
Johannesburg 20
Phoenix 20
Mumbai 19
Amsterdam 16
Washington 16
London 15
Pune 15
Seattle 15
Augusta 14
Chennai 14
Manchester 14
Ningbo 14
Rio de Janeiro 14
Ardabil 13
Da Nang 13
Kunming 13
Stockholm 13
Turku 13
Mexico City 12
Redondo Beach 12
Boston 11
Denver 11
Norwalk 11
Curitiba 10
Den Haag 10
Guarulhos 10
Poplar 10
Rome 10
San Francisco 10
Biên Hòa 9
Dhaka 9
Grafing 9
Jinan 9
Paris 9
Brasília 8
Falls Church 8
Frankfurt am Main 8
Jyväskylä 8
Liberty Lake 8
Naples 8
Baghdad 7
Totale 10.788
Nome #
(E)-alpha-[[(5-Substituted)1H-indol-3-yl]methylene]benzeneacetic Acid and Amide Derivatives: Synthesis, Characterization, and Evaluation of in vitro Antiproliferative Activity 316
3-Arylpiperazynilalkyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives: as novel, potent and selective alpha1-adrenoceptor ligands 294
V. Sorrenti, C. Di Giacomo, L. Salerno, M.A. Siracusa, F. Guerrera, and A. Vanella Novel imidazole derivatives as selective nNOS inhibitors 242
[1,2,4]Triazole derivatives as 5-HT1A serotonin receptor ligands 232
"Lipid nanoparticles based on crocin and crocetin : antioxidant activities and anticancer properties" 195
1-[(aryloxy)alkyl]-1H-imidazoles as inhibitors of neuronal nitric oxide synthase. 194
1-[(Aryloxy)alkyl]-1H-imidazoles as selective inhibitors of neuronal nitric oxide synthase. 192
(E)-alfa-[[(5-Substituted)1H-indol- 3-yl]methylene]benzeneacetic acid and amide derivatives: synthesis, characterization, and evaluation of in vitro antiproliferative activity 169
(E)-?-[[(5-Substituted)1H-indol-3-yl]methylene]benzeneacetic Acid and Amide Derivatives: Synthesis, Characterization, and Evaluation of in vitro Antiproliferative Activity 169
A focus on Heme Oxygenase-1 (HO-1) inhibitors 164
(E)-alfa-[[(5-substituted)1H-indol-3-yl]methylene]benzeneacetic acid and amide derivatives: synthesis, characterization, and evaluation of in vitro antiproliferative activity 159
3-ARILPIPERAZINILALCHILPIRROLO[3,2-d]PIRIMIDIN-2,4-DIONE: UNA NUOVA CLASSE DI LIGANDI POTENTI ED ALTAMENTE SELETTIVI PER I RECETTORI a 1-ADRENERGICI 156
3-Arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high affinity and selective alpha1-adrenoceptor ligands 156
3-Arilpiperazinilalchilpirrolo[3,2-d]pirimidin-2,4-dioni: una nuova classe di ligandi potenti e selettivi per il recettori alfa1-adrenergici 155
5-HT7 receptor ligands: recent developments and potential therapeutic applications 148
Antioxidant Activity and Phenolic Content of Microwave-Assisted Solanum melongena Extracts 148
Antitumor properties of substituted (alpha E)-alpha-(1H-indol-3-ylmethylene)benzeneacetic acids or amides 146
A New benzoxazolone and benzothiazolone derivatives as potential 5-HT7 receptor ligands 146
3-Arylpiperazynilalkyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives: as novel, potent and selective a1-adrenoceptor ligands 144
3-Arylpiperazinylalkyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione Derivatives: Novel, Potent and Selective alfa1-Adrenoceptor Ligands 141
4-Isothiazole carbonitriles active against measles virus 141
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 135
3-Methylthio-5-(4-ots)-phenyl-4-isothiazolecarbonitrile (IS-44): a new potential HRV capsid-binder 135
Analysis of mechanisms for memory enhancement using novel and potent 5-HT1A receptor ligands 132
Design and synthesis of new homo and hetero bis-piperazinyl-1- propanone derivatives as 5-HT7R selective ligands over 5-HT1AR 132
A Facile Synthesis of New 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxyamido-3-carboxythieno[2,3-c]pyridine Derivatives as Potential Endothelin Receptors Ligands 132
3-Arylpiperazynilalkyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives: as novel, potent and selective alfa1-adrenoceptor ligands 128
3-Arylpiperazinylalkyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives: novel, potent and selective alpha1-adrenoceptor ligands 126
Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole, derivatives as potent and selective 5-HT1A serotonin receptor ligands 126
New 1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives: Analogues of HEAT as ligands for the alpha(1)-adrenergic receptor subtypes 122
Inhibition of nitric oxide synthase (NOS) by some N-substituted imidazoles. 122
Synthesis and pharmacological properties of 2-nitro-3-substituted-amino benzo[b]thiophenes and their 5-chloro derivatives 121
Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT7 and 5-HT1A receptor ligands 120
Novel inhibitors of neuronal nitric oxide synthase 119
Synthesis of new 3-methylthio-5-aryl-4- isothiazolecarbonitriles with broad antiviral spectrum 118
Synthesis of novel 4,5-diphenylthiazole derivatives as potential acylCoA:cholesterol O-acyltransferase inhibitors 115
Selective inhibition of neuronal nitric oxide synthase by imidazole derivatives. 113
Synthesis and antifungal activity of pyrido[3',2':4,5] thieno[3,2-d]-1,2,3-triazine derivatives 111
Acidi (E)-alfa-[(1H-indol-3-il)metilene]benzeneacetici: una nuova classe di ligandi per i recettori delle endoteline 111
Synthesis of Novel Benzylpiperazine Derivatives as Ligands for the σ1 Receptor 111
Isoxazoles with antiviral activity 109
Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties 107
Isothiazole derivatives as novel HIV replication inhibitors. 105
Synthesis and antiviral activity of new 3-(dialkylamino)-5-phenyl-4-isothiazole-carbonitriles 105
Serotonin 5-HT3 and 5-HT4 Ligands: An Update of Medicinal Chemistry Research in the Last Few Years 104
Evaluation of Novel Imidazole- and 1,2,4 Triazole-based Compounds as Heme Oxygenase-1 (HO-1) Inhibitors. 104
Synthesis and antiviral activity of a new series of 4-isothiazolecarbonitriles 104
New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies 102
Synthesis and Binding Properties of New Endothelin Receptor Ligands 102
Synthesis and fungistatic activity of 3-(2-dialkylaminoethylthio)thieno [2,3-c] and [3,2-d] isothiazole derivatives 101
Synthesis and pharmacological evaluation of benzothieno and [1]pyridothieno [2,3-d]triazole derivatives as antagonists at NK-1 receptors 101
Isothiazoles as potent and broad spectrum antiviral agents 100
SYNTHESIS OF 1,2,4-TRIAZOLE DERIVATIVES: BINDING PROPERTIES ON ENDOTHELIN RECEPTORS 99
Synthesis and endothelin receptor binding affinity of a novel class of 2-substituted-4-aryl-3-quinolinecarboxylic acid derivatives 98
ATTIVITÀ ANTIMICROBICA DI DERIVATI TRIAZOLICI 96
Design and synthesis of novel potential ligands for endothelin receptors 96
Isothiazoles with antiviral activity 96
Synthesis and Endothelin Receptors Binding Affinity of New 1,3,5- Substituted Pyrrole-2-Carboxylic Acid Derivatives 95
Nuovi Arilpiperazinilalchilpirrolopirimidindioni come ligandi potenti e selettivi per i recettori α1-adrenergici 95
Synthesis and spectral behaviour of pyridothienoisothiazole and pyridothienopyrimidine derivatives 95
Synthesis and endothelin receptor binding affinity of a novel class of (E)-α-[[(5-phenylmethoxy)-1H-indol-3-yl]methylene]benzeneacetic acids 94
Isothiazole derivatives as potent antiadenovirus agents 94
ATTIVITÀ ANTIMICROBICA DI DERIVATI TRIAZOLICI 93
SYNTHESIS OF NOVEL 1-ALKYL OR 1-ARYL-2-(4-SUBSTITUTED-1-PIPERAZINYL)-1H-BENZOTHIENO [2,3-D]IMIDAZOLES 93
Synthesis of substituted thieno[2,3-c]- and [3,2-d]isothiazoles 92
ACIDI (E)-a-[(1H-INDOL-3-IL)METILENE]BENZENEACETICI: UNA NUOVA CLASSE DI LIGANDI PER I RECETTORI DELLE ENDOTELINE 92
Sintesi di 1,2,4 Triazoli come Ligandi per i Recettori delle Endoteline 91
SINTESI DI LIGANDI SELETTIVI PER I RECETTORI alfa1-ADRENERGICI 91
Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for alpha1-adrenoceptor subtypes. 91
Synthesis and analgesic antiinflammatory activities of 2-aryl-ethenyl-4-aryl-thiazole-5-acetic acids 90
Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as novel ligands for the 5-HT7 receptor 89
Synthesis of new 5-phenyl[1,2,4]triazole derivatives as ligands for the 5-HT1A serotonin receptor 87
Synthesis and Biological Activity of 1-, 2- or 3-Substituted Benzothieno[2,3-d]triazole Derivatives Structurally related to Trazodone. 86
Synthesis and endothelin receptor binding affinity of a novel class of 2-substituted-4-aryl-3-quinoline carboxylic acid derivatives 86
Synthesis and pharmacological properties of 2-nitro-3-substituted-aminobenzo b thiophenes and 1-substituted benzothieno 2,3-d imidazoles 85
Inhibition of Neuronal Nitric Oxide Synthase by N-Phenacyl Imidazoles 85
Synthesis and pharmacologic activity of 2-arylethenylthiazol-4-acetic and 4-carboxylic acids 85
Synthesis and pharmacological properties of 3-alkylthio derivativies of isothiazolothieno-1,2,3-triazine 84
Benzothieno[3,2-d]pyrimidine ligands with high affinity for human α1-adrenergic receptor subtypes 84
N-Phenacyl imidazoles as nNos inhibitors 83
Design and Synthesis of Novel Potential Ligands for Endothelin Receptors 83
Acidi (E)-[(1H-Indol-3-il)metilene]benzeneacetici: una Nuova Classe di Ligandi per i Recettori delle Endoteline 83
Imidazole derivatives as antioxidants and selective inhibitors of nNOS 82
Synthesis of 5-substituted-3-phenacyloxime-1,2,4-oxadiazoles from acetylated or benzoylated benzoylthiacetamide with hydroxylamine hydrochloride. Spectral evidence for a tetrahedral carbinolamine intermediate 81
Arylpiperazinylalkylthio benzothiazole or benzoxazole derivatives as selective 5-HT1A serotonin receptor ligands 80
Progress in the development of selective nitric oxide synthase (NOS) inhibitors 80
N-substuted-imidazoles as inhibitors of nitric oxide synthase: a preliminary screening. 80
Design and Synthesis of New 3-Aryl-5-oxoprolines as Potential Ligands for Human Cloned Endothelin Receptors 79
Novel arylpiperazine ligands with high affinity for alpha1-adrenergic receptor subtypes 79
New compounds controlling NO overproduction 78
New benzoxazole and benzothiazole derivatives as potential 5-HT7 receptor ligands 78
Synthesis and endothelin receptor binding affinity of a novel class of (E)-alpha-[[(5-phenylmethoxy)-1H-indol-3-yl]methylene]benzeneacetic acids 78
Novel Caffeic Acid Phenethyl Ester (CAPE) Analogues as Inducers of Heme Oxygenase-1 78
Caffeic Acid Phenethyl Ester (CAPE) derivatives as novel heme oxygenase-1 inducers. 78
Thieno[3,2-d]pyrimidine as a scaffold for 5-HT7 receptor ligands 78
New Pyrimido[5,4-b]indoles and [1]Benzothieno[3,2-d]pyrimidines. High Affinity Ligands for the a 1 - Adrenoceptor Subtypes 78
Synthesis of 1,3,5-substituted pyrroles as potential endothelin receptor ligands 77
Novel imidazole derivatives as selective nNOS inhibitors 76
Thioamide derivatives with gastro-protective activity 75
Caffeic acid phenetyl ester (CAPE) derivatives as novel heme oxygenase-1 inducers 75
Totale 11.501
Categoria #
all - tutte 50.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 0 0 0 0 0 0 112
2021/20221.199 160 174 1 12 187 14 168 32 130 4 33 284
2022/20231.894 174 91 20 166 177 365 0 339 480 16 55 11
2023/2024722 42 131 26 38 46 140 0 62 5 17 124 91
2024/20253.198 30 439 196 204 589 285 258 194 312 260 206 225
2025/20266.339 363 196 1.373 331 1.011 1.173 830 104 323 355 165 115
Totale 15.670